ConductScience.org, home

Library / Trials

The Skin as a Window to the Central Nervous System in Frontotempolar Lombar Degeneration

NCT06490822, Not applicable, Recruiting, Nantes University Hospital

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleThe Skin as a Window to the Central Nervous System in Frontotempolar Lombar DegenerationClinicalTrials.gov
NCT numberNCT06490822ClinicalTrials.gov
StatusRecruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment80 participants, estimatedClinicalTrials.gov
Lead sponsorNantes University HospitalClinicalTrials.gov
ConditionsFrontotemporal Lobar DegenerationClinicalTrials.gov
InterventionsSkin biopsyClinicalTrials.gov
First posted2024-07-08ClinicalTrials.gov
Last updated2024-12-20ClinicalTrials.gov

Registered outcomes 7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryAmount of TDP 43Day of inclusionassessed by Western blot and qPCR to determine level of expression of TDP-43 in the skinClinicalTrials.gov
PrimaryAmount of Tau assessed by Western blot and qPCRDay of inclusionassessed by Western blot and qPCR to determine level of expression of Tau in the skinClinicalTrials.gov
SecondaryAmount of Tau phosphorylationDay of inclusionphospho-tau/tau ratio in the skin will be measured by Western blotClinicalTrials.gov
SecondaryAmount of TDP 43 phosphorylationDay of inclusionphospho-TDP-43 /TDP43 ratio in the skin will be measured by Western blotClinicalTrials.gov
SecondaryNeuropsychological characterizationday of inclusion for patients vFTD, PPA and corticobasal degeneration-CBD and progressive supranuclear palsy-PSP within 12 months of inclusion for patients ALS
During their follow-up FTLD patients underwent a complete neuropsycological assessment define as: * mini-mental state examination (MMSE) * the 16-item Free Recall/Indicated Recall test (RL/RI-16 items) * Rey figure and recall * Trail Making Test (TMT A \& B) * Wechsler Adult Intelligence Scale * Literal (letter P) and categorical (animals) fluency * Rapid Frontal Efficiency Battery (BREF) * Wisconsin Card Sorting Test (WCST) * Zoo test of Behavioural Assessment of the Dysexecutive Syndrome (BADS) * Stroop test - 4 boards * Oral image naming test (DO 80) * Theory of mind (ToM-15) * ekman facial emotion recognition test
ClinicalTrials.gov
SecondaryBehaviour profileday of inclusion for patients vFTD, PPA and corticobasal degeneration-CBD and progressive supranuclear palsy-PSP within 12 months of inclusion for patients ALSThe 10-items scale Daphne will be used to explore disinhibition (4 items), apathy(1 item), perseveration (1 item), hyperorality (2items), personal neglect (1 item) and loss of empathy (1 item)ClinicalTrials.gov
SecondaryFTLD mutationbefore inclusionMutation carrier patient will be identified among participant (not all the participant) who had a genetic screening had neen carried out during their follow up.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 4

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Card Sorting Test (Berg)Secondary outcomeConductCognition
Emoji Emotion RecognitionSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)